james333 Hi has anyone had a pop up Product licence invalid when trying to optimise trial robot. It says You have selected the option "single trade/account" no orders will open if there is a single order already open. Read user guide for more information. I have No in settings for single trade. Is it because it is the trial product? and when purchase the real product do I keep my bots. Thanks
james333 Hi Sebastian it is the EURUSD trading bot seems to be taking and selling orders one win and 4 in the red at the moment . Letting it run, but would like to get it tuned and actually start live. Thanks for getting back Mike support seems great . https://clickalgo.com/eurusd-trading-robot
Sophia To answer your original question, you will find help in the user guide. https://clickalgo.com/neptune-adjustable-settings Just set the disable warning to no, also read up about the single trade account as stated in the warning popup.
james333 Thanks Sophia , there are so many adjustments, it will take a while but thanks your help and advice. I'm starting to really like it. Will the bots be the same when I purchase the real product or do I need to reset everything. Thanks regards James
Sophia Hi James, As with all our products, you will download the paid version and remove the trial version. You can find more information about our services below. https://clickalgo.com/clickalgo-welcome-video https://clickalgo.com/downloading-software
eco The bot Is borderline unworkable as a trial. I have done all things requested and I am still being swamped by the license messages. please help, the backtest results were AWFUL and I want to optimise to see if its worth purchasing.
Sophia Hi, Eco, please provide more information, which product are you having issues with registering?
eco Hello, It’s the GBP/USD trial bot. I have unselected warning etc but I get notifications every other second regarding single trade accounts?
Sophia did you set this value to false to turn it off? we are also having problems with our license server, so you may experience trial validation issues.